Spyre Therapeutics (SYRE) Shares Outstanding: 2015-2024
Historic Shares Outstanding for Spyre Therapeutics (SYRE) over the last 7 years, with Sep 2024 value amounting to $51.4 million.
- Spyre Therapeutics' Shares Outstanding rose 1169.35% to $51.4 million in Q3 2024 from the same period last year, while for Sep 2024 it was $51.4 million, marking a year-over-year increase of 1169.35%. This contributed to the annual value of $36.1 million for FY2023, which is 1279.38% up from last year.
- Latest data reveals that Spyre Therapeutics reported Shares Outstanding of $51.4 million as of Q3 2024, which was up 1.21% from $50.8 million recorded in Q2 2024.
- Spyre Therapeutics' Shares Outstanding's 5-year high stood at $51.4 million during Q3 2024, with a 5-year trough of $2.0 million in Q4 2021.
- Moreover, its 3-year median value for Shares Outstanding was $3.2 million (2023), whereas its average is $17.7 million.
- As far as peak fluctuations go, Spyre Therapeutics' Shares Outstanding tumbled by 95.97% in 2022, and later soared by 1,467.38% in 2024.
- Quarterly analysis of 5 years shows Spyre Therapeutics' Shares Outstanding stood at $48.0 million in 2020, then tumbled by 95.88% to $2.0 million in 2021, then soared by 32.42% to $2.6 million in 2022, then spiked by 1,279.38% to $36.1 million in 2023, then soared by 1,169.35% to $51.4 million in 2024.
- Its Shares Outstanding was $51.4 million in Q3 2024, compared to $50.8 million in Q2 2024 and $36.6 million in Q1 2024.